INVIVO THERAPEUTICS

Codice
nviv
Risorse esterne
Opinione della community
Prezzo Variazione Volume
4.55 0 €
(0.00%)
0
P/E Obiettivo ad 1anno
0 19.42 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 20
Sell : 2

Simone Bonzanini parcall LucaMazzu91

Commenti


Notizie

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Option Trading Long Puts and Earnings - CML News

As we look at InVivo Therapeutics Holdings Corp. we note that a long put is one of the most common implementations of an option strategy, but the analysis completed when employing the long put often times lacks the necessary rigor especially ... Leggi

Top Stock With Upside & Growth Potential: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - Prospect Journal

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares have been labeled a top pick by Beta Research as it meets the guidelines tracked by the firm. The stock boasts an analyst “Buy” rating with the consensus recommendation standing at 1.30. This is ...altro » Leggi

InVivo Therapeutics Announces University of New Mexico Hospital ... - Business Wire (press release)

InVivo Therapeutics Holdings Corp. (NVIV) today announced that the University of New Mexico Hospital (UNMH) in Albuquerque, NM has been added as.altro » Leggi

InVivo Therapeutics Holdings Corp. (NVIV) Moves Higher on Volume Spike for January 10 - Equities.com

InVivo Therapeutics Holdings Corp. (NVIV) traded on unusually high volume on Jan. 10, as the stock gained 8.43% to close at $4.50. On the day, InVivo Therapeutics Holdings Corp. saw 466,486 shares trade hands on 1,465 trades. Considering that the stock ... Leggi

Consensus Review & Target Check on Invivo Therapeutics Holdings Corp (NYSE:NVIV) - Liberty News

During the most recent trading session, shares of Invivo Therapeutics Holdings Corp (NYSE:NVIV) ended up with a move of +2.25%. Sell-side analysts have given a consensus target price of $19.42 on company shares. Target price projections may differ ...altro » Leggi

InVivo Therapeutics Holdings Corp. (NVIV) Soars 7.23% on January 04 - Equities.com

InVivo Therapeutics Holdings Corp. (NVIV) had a good day on the market for Wednesday January 04 as shares jumped 7.23% to close at $4.45. About 413,149 shares traded hands on 1,762 trades for the day, compared with an average daily volume of ...altro » Leggi

INVIVO THERAPEUTICS HOLDINGS CORP. (NASDAQ:NVIV) Files An 8-K Regulation FD Disclosure - Market Exclusive

The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program ...altro » Leggi

InVivo Therapeutics Holdings Corp. (NVIV) Plunges 5.68% on December 19 - Equities.com

InVivo Therapeutics Holdings Corp. (NVIV) had a rough trading day for Monday December 19 as shares tumbled 5.68%, or a loss of $-0.25 per share, to close at $4.15. After opening the day at $4.35, shares of InVivo Therapeutics Holdings Corp. traded as ...altro » Leggi

Trading Covered Calls: InVivo Therapeutics Holdings Corp ... - CML News

As we look at InVivo Therapeutics Holdings Corp. we note that a covered call is one of the most common implementations of an option strategy, but the analysis ...altro » Leggi

InVivo Therapeutics Responds to PixarBio Announcement - Business Wire (press release)

InVivo Therapeutics Corporation was not privy to the announcement made today and has not had any discussions with PixarBio Corporation nor any other party regarding this matter. ... The publicly-traded company is headquartered in Cambridge, MA. Leggi